For Pharma

Real-World Clinical Data. Ethically Accessed.

Pharma companies need real-world clinical data. Hospitals have it but can't share it safely. We built the bridge -- de-identified, consent-driven, compliant, and connected to hospital workflows.

0M+
De-identified Lives in the repository
0+
Data Partner Centres across India
0%
Consent-Driven -- no exceptions
0+
Clinical Protocols for gap and adherence tracking

Pharma Capabilities

Real-world evidence, therapy adherence, patient support -- all running on the clinical data platform hospitals already use.

RW

Real-World Clinical Data

De-identified, longitudinal clinical data across multiple hospital systems. Lab results, medication history, visit patterns, treatment outcomes. 18 months of depth per patient. The data already exists -- we make it accessible.

TA

Therapy Adherence Programs

Track medication compliance through refill patterns, lab trends, and visit frequency. Identify non-adherent patients early -- before they drop off the therapy. Integrated into hospital workflows, not a standalone system.

PS

Patient Support Programs

Educational content, appointment reminders, follow-up coordination -- all through the patient's preferred channel. Integrated with hospital care teams. Not another app the patient has to download.

TP

Treatment Pathway Analysis

What drugs are prescribed, in what sequence, with what outcomes. Compare protocol adherence across hospitals and patient segments. Real-world treatment data, not what the guidelines say should happen.

CD

Consent-Driven Data Sharing

Patient-level consent management, de-identification pipelines, audit trails on every data access. Compliant with Indian data protection regulations. No consent, no access. Period.

MA

Multi-Hospital Aggregation

Insights aggregated across 5,000+ hospital partners. Larger sample sizes, more representative data. The network is the moat -- and it took years to build.

Pharma Use Cases

Three real scenarios. Not hypothetical -- these are the conversations we have with pharma companies.

Therapy Adherence Monitoring

A diabetes drug manufacturer wants to know why patients discontinue after 3 months. THB provides de-identified longitudinal data: refill patterns, HbA1c trends, visit frequency, correlated factors. They discover patients without regular endocrinologist follow-ups are 3x more likely to drop off. So they build a targeted support program that integrates follow-up reminders into the hospital's existing workflow through PEP. Data drove the insight. The platform delivered the intervention.

3x discontinuation risk identifiedFollow-up reminder integrationDe-identified longitudinal data

Patient Support Program Integration

A cardiac drug company launches a support program for post-MI patients. Instead of building yet another patient app nobody downloads, they integrate through THB's multi-channel platform. Patients get medication reminders, exercise guidance, diet recommendations on WhatsApp -- in their language -- as part of their hospital's existing care plan. The hospital care team sees engagement data alongside clinical metrics. No new app. No adoption problem.

WhatsApp-native engagementHospital workflow integrationBilingual communication

Real-World Evidence Generation

A pharma company needs real-world evidence for a regulatory submission. THB provides de-identified treatment pathway data across multiple hospitals: drug sequences, dosage patterns, lab outcomes, adverse event signals, demographics. 18 months of longitudinal depth across thousands of patients. Complete audit trails and consent documentation. The kind of evidence regulators actually accept.

18-month longitudinal depthMulti-hospital aggregationComplete audit trails

Data Governance & Compliance

Every data access audited, consent-verified, compliant. This is the foundation. Without it, nothing else matters.

CM

Patient Consent Management

Granular tracking

Granular consent tracking: per patient, per data type, per use case. Consent checked at query time. No active consent? No access. Patients can revoke through the hospital at any time, and it takes effect immediately.

Per-PatientQuery-Time CheckRevocable
DI

De-Identification Pipeline

Multi-stage removal

Multi-stage de-identification pipeline removes all patient identifiers before any data reaches pharma partners. PII protected with column-level encryption. K-anonymity enforced for small cohorts. No shortcuts.

PII RemovalK-AnonymityEncrypted
AL

Audit Trail

Complete traceability

Every data access logged: who, what, when, why. Partitioned audit tables. Complete traceability for regulatory compliance and internal governance. If a regulator asks, we have the answer.

PartitionedRegulator-Ready
RC

Regulatory Compliance

DPDPA + HIPAA + GxP

Aligned with India's Digital Personal Data Protection Act (DPDPA), HIPAA standards, and GxP requirements. Regular compliance audits. Data processing agreements with all hospital partners.

DPDPAHIPAAGxP

Pharma Solutions Suite

Four purpose-built solutions for pharma, all running on the same clinical data platform hospitals already use.

HE

HCP Engagement & Digital Med Rep

Digital field force tools for HCP engagement, sample management, territory analytics. Your field reps become data-driven.

RW

Real World Clinical Evidence

Generate RWE from de-identified data across 5,000+ partner centres. Regulatory submissions, research, market access -- all from one data asset.

SC

Smart Contact Centre

AI-powered patient engagement via WhatsApp, SMS, voice. Therapy adherence reminders, follow-up coordination, patient support -- integrated with hospital workflows.

EJ

ERWEJournal

Our proprietary RWE publication platform. Researchers and clinicians publish and access real-world clinical evidence. 100+ publications and growing.

Explore Pharma Use Cases

Therapy adherence, patient support, real-world evidence -- tell us what you need. We will show you the data and the delivery mechanism.